ethyl 2-(6-methoxyquinolin-4-yl)acetate, 97.0%, 100mg

Methyl-(R)-pyrrolidin-3-yl-carbamic acid tert-butyl ester, 98.0%, 5g

3,4-DIHYDRO-1H-PYRROLO[1,2-A]PYRAZINE-2,6-DICARBOXYLIC ACID 2-TERT-BUTYL ESTER 6-METHYL ESTER, 95.0%, 250mg

6,6'-Dibromo-2,2'-bipyridyl>95.0%(GC)1g

Tetrazolio violetto, per microscopia, 10 g, confezione in vetro

2-Fluoro-4-nitrobenzoic acid, 97.0%, 25g

(4-(4-Methylthiazol-5-yl)phenyl)methanamine, 95.0%, 1g

4-(2-chlorophenyl)-3H,4H,5H,6H,7H-imidazo[4,5-c]pyridine-6-carboxylic acid, 95.0%, 1g

3-Bromomethyl-pyrrolidine-1-carboxylic acid tert-butyl ester, 95.0%, 5g

6-(3-(Cyclopropylmethoxy)-4-methoxyphenyl)-3-(2,5-dimethoxyphenyl)-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine, 95%, 250mg

5,6-Dihydro-1,4-dithiin-2,3-dicarboxylic Anhydride>98.0%(GC)5g

Colonna capillare per GC ROTI®Cap-1701, 10 m, 0,32 mm, 0,25 µm, 1 Pezzo(i)

2-[[4-[[4-[Bis-(2-hydroxyethyl)-amino]-phenyl]-(4-chloro-phenyl)-methyl]-phenyl]-(2-hydroxy-ethyl)-amino]-ethanol, 250mg